- idUS
- Listar por autor
Listar por autor "Martín, Miguel"
Mostrando ítems 1-4 de 4
-
Artículo
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain
Martín, Miguel; Guerrero-Zotano, Ángel; Montero, Ángel; Jara, Carlos; Filipovich, Elena; Rojo, Federico; Cruz Merino, Luis de la; López Tarruella, Sara (2020)Breast cancer (BC) is the most common cancer in women in Spain. During the COVID-19 pandemic caused by the SARS-CoV-2 ...
-
Artículo
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
Lluch, Ana; Barrios, Carlos H.; Torrecillas, Laura; Ruiz-Borrego, Manuel; Bines, José; Guerrero-Zotano, Ángel; Salvador Bofill, Francisco Javier; Martín, Miguel (American Society of Clinical Oncology, 2020)PURPOSE Operable triple-negative breast cancers (TNBCs) have a higher risk of relapse than non-TNBCs with standard ...
-
Artículo
Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor-positive, HER2-negative, node-negative early-stage breast cancer
Martín, Miguel; González-Rivera, Milagros; Morales, Serafín; De La Haba-Rodriguez, Juan; González-Cortijo, Lucía; Manso, Luis; Albanell, Joan; Cruz Merino, Luis de la; Prat, Aleix (Taylor and Francis Group, 2015)Purpose: Improved understanding of risk of recurrence (ROR) is needed to reduce cases of recurrence and more effectively ...
-
Artículo
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
Salvador Bofill, Francisco Javier; Moreno Antón, Fernando; Rodríguez Sánchez, César Augusto; Galve Calvo, Elena; Hernando Melia, Cristina; Ciruelos Gil; Cruz Merino, Luis de la; Martín, Miguel (Elsevier, 2022)Background: Breast cancer is the most common malignancy and the second leading cause of cancer-related mortality in ...